Michael R Hayden
Director at AbCellera Biologics Inc. (ABCL); Director at Ionis Pharmaceuticals Inc (IONS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$50K
Total bought / sold$2.1M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 24SEC | ABCLAbCellera Biologics Inc. | Buy | 53,6131,373,397 held (+4%) | $10.64 | $570K | +17.9% |
| Aug 14SEC | ABCLAbCellera Biologics Inc. | Buy | 46,3871,319,784 held (+4%) | $10.37 | $481K | +21.0% |
| Jul 31SEC | IONSIonis Pharmaceuticals Inc | Buy | 15,00019,000 held (+375%) | $53.38 | $801K | -15.2% |
| Jul 31SEC | IONSIonis Pharmaceuticals Inc | Buy | 5,00024,000 held (+26%) | $51.60 | $258K | -12.2% |
- Buy
Director Michael R Hayden bought $570K of ABCL at $10.64 — largest purchase by this insider in our records.
- Buy
Director Michael R Hayden bought $481K of ABCL at $10.37 — first open-market purchase in our records.
- Buy
Director Michael R Hayden bought $801K of IONS at $53.38 — first open-market purchase in our records; raises the stake by 375%.
- Buy
Director Michael R Hayden bought $258K of IONS at $51.60 — raises the stake by 26%.